TAKEDA PHARMACEUTICALS U.S.A., INC.
ent_019e591ef854dfd2d55dded0273b6ada
Disclosures
8
State AG · 7 jurisdictions
Multi-filing incidents
2
incidents joining 2+ filings here
Max affected reported
2,435
nationwide · State AG TX
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- TAKEDA PHARMACEUTICALS U.S.A., INC.
- Normalized
- takeda pharmaceuticals usa— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 549300W0D7WG0MRLHP67
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- None on record
- Corporate parent
- 武田薬品工業株式会社— per GLEIF relationship records
Disclosure history (8)newest first
- Texas State AGas victim2026-06-26
Takeda Pharmaceuticals USA, Inc. based in Cambridge, Massachusetts, a other entity reported a data breach to the Texas Attorney General. The breach was discovered on 2026-02-23 and reported on 2026-06-26. 392 Texas residents were affected. 2,435 individuals affected in total. Types of information involved: Name of individual;Address;Social Security Number Information;Driver’s License number;Government-issued ID number (e.g. passport, state ID card);Medical Information;Date of Birth. Consumers were notified via U.S. Mail.
- Massachusetts State AGas victim2026-05-30
Takeda Pharmaceuticals USA, Inc. notified Massachusetts residents of a security incident discovered on February 23, 2026, where an unauthorized third party compromised an employee's credentials. The incident involved access to personal information including names. Takeda contained the incident, notified law enforcement, and offered 24 months of Experian IdentityWorks services.
- New Hampshire State AGas victim2026-05-29
Takeda Pharmaceuticals USA, Inc. notified the New Hampshire Attorney General of a security incident where an unauthorized third party compromised employee credentials via voice phishing (vishing) around February 9, 2026. The actor exfiltrated files containing personal information (name, SSN, DOB, driver's license) of 5 New Hampshire residents between February 9 and 21, 2026. Takeda discovered the breach on February 23, 2026, contained it, and began notifying affected individuals on May 29, 2026, offering 24 months of credit monitoring.
- Massachusetts State AGas victim2025-07-10
Takeda Pharmaceuticals U.S.A., Inc. reported a data breach to the Massachusetts Office of Consumer Affairs and Business Regulation. The breach was reported on 2025-07-10. 1 Massachusetts residents were affected.
- Montana State AGas victim2024-05-31
Cencora, Inc. notified Montana residents of a data security incident where personal and health information was exfiltrated from its information systems. Cencora discovered the unauthorized access on February 21, 2024, and confirmed affected data on April 10, 2024. Affected data included names, addresses, DOB, and health diagnoses. Cencora engaged law enforcement and cybersecurity experts, and is offering 24 months of credit monitoring.
- Washington State AGas reporting2024-05-31
Cencora, Inc. reported a cyberattack on February 21, 2024, involving the exfiltration of personal information including names, addresses, DOBs, and health diagnoses from its Lash Group affiliate. 889 Washington residents were affected. Cencora engaged law enforcement and forensic experts, contained the incident, and offered 24 months of credit monitoring.
- California State AGas victim2024-05-31
Cencora, Inc. notified the California Attorney General of a data breach involving its Lash Group affiliate. On February 21, 2024, Cencora learned that data from its information systems had been exfiltrated. The incident potentially affected personal information including names, addresses, dates of birth, health diagnoses, and medications. Cencora engaged law enforcement and cybersecurity experts, took containment steps, and is offering 24 months of credit monitoring to affected individuals.
- Vermont State AGas victim2024-05-31
Cencora, Inc. experienced a data breach on February 21, 2024, resulting in the exfiltration of personal information including names, addresses, dates of birth, health diagnoses, and medications. Lash Group, a partner, notified affected consumers on May 31, 2024. Cencora engaged law enforcement and cybersecurity experts, and offered 24 months of credit monitoring.